Semaglutide belongs to the GLP-1 (glucagon-like peptide) class of drugs, one of the most advanced medicines currently in use for treating diabetes and obesity
The dose is then increased by 0.6 mg each week until you reach the target dose of 3.0 mg daily for weight loss
Brandon Richland, MD Wegovy, the brand name for semaglutide, is gaining significant attention as a groundbreaking treatment in weight loss management
B-12 helps the body process fats and proteins efficiently
Important safety considerations during titration: If you are taking insulin or a sulfonylurea alongside Mounjaro, your doctor may need to reduce these doses to prevent hypoglycaemia, particularly when starting or increasing your Mounjaro dose
Okojie, who is available five days a week to get you started